The UK on Wednesday became the first country to approve a Covid-19 vaccine developed by Pfizer and its partner BioNTech, a decision that will likely put pressure on the FDA to move swiftly to do the same. The vaccine is also the first to run the gauntlet of clinical studies normally required for approval.